marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q2
hinzugefügt 07.08.2024
Keros Therapeutics Bilanz 2011-2024 | KROS
Bilanz Jährlich Keros Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-317 M | -266 M | -229 M | -265 M | -5.74 M | -22.5 M | - | - | - | - | - | - | - |
Langfristige Schulden |
13.4 M | 12.8 M | 231 K | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
1 M | 455 K | 862 K | 423 K | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 538 K | 1.02 M | 3.18 M | - | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
24.4 M | 16.5 M | 11.8 M | 7.18 M | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
37.8 M | 29.4 M | 12.1 M | 7.72 M | 5.5 M | 14.7 M | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | 10 M | - | - | - | - | - | - | - |
Gewinnrücklagen |
-381 M | -228 M | -124 M | -65 M | -19.6 M | -7.31 M | - | - | - | - | - | - | - |
Vermögenswerte |
370 M | 307 M | 255 M | 269 M | 11 M | 27.4 M | - | - | - | - | - | - | - |
Zahlungsmittel |
331 M | 279 M | 230 M | 266 M | 7.14 M | - | - | - | - | - | - | - | - |
Buchwert |
332 M | 277 M | 243 M | 262 M | 5.45 M | 12.8 M | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
332 M | 277 M | 243 M | 262 M | -19.4 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Keros Therapeutics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
12.9 M | 13.2 M | 13.4 M | 13.7 M | 14 M | 14 M | 12.8 M | - | - | - | 231 K | 453 K | 242 K | 361 K | 476 K | 476 K | 476 K | 476 K | 899 K | 899 K | 899 K | 899 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
34.1 M | 31.9 M | 37.8 M | 30.4 M | 30 M | 29.5 M | 29.4 M | 11.5 M | - | 11.6 M | 12.1 M | 11.5 M | 7.8 M | 9.36 M | 7.72 M | 7.72 M | 7.72 M | 7.72 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-470 M | -425 M | -381 M | -341 M | -302 M | -264 M | -228 M | -199 M | - | -148 M | -124 M | -117 M | -96.5 M | -80.9 M | -65 M | -65 M | -65 M | -65 M | -19.6 M | -19.6 M | -19.6 M | -19.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
455 M | 486 M | 370 M | 326 M | 356 M | 384 M | 307 M | 253 M | - | 235 M | 255 M | 230 M | 243 M | 258 M | 269 M | 269 M | 269 M | 269 M | 11 M | 11 M | 11 M | 11 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
406 M | 442 M | 331 M | 288 M | 322 M | 351 M | 279 M | 239 M | 216 M | 229 M | 230 M | 221 M | 237 M | 255 M | 266 M | 266 M | 266 M | 266 M | 7.02 M | 7.02 M | 7.02 M | 7.02 M | 23.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
421 M | 454 M | 332 M | 296 M | 326 M | 355 M | 277 M | 241 M | - | 223 M | 243 M | 218 M | 236 M | 248 M | 262 M | 262 M | 262 M | 262 M | 495 K | 495 K | 495 K | 495 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
421 M | 454 M | 332 M | 296 M | 326 M | 355 M | 277 M | 241 M | 211 M | 223 M | 243 M | 218 M | 236 M | 248 M | 262 M | 262 M | 262 M | 262 M | -19.4 M | -19.4 M | -19.4 M | -19.4 M | -7.18 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung